CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-28 | Fromkin Andrew J. Director | Option exercise · Stock Option (right to buy) | −71,492 | 0 | ||
| 2026-05-28 | Fromkin Andrew J. Director | Option exercise · Stock Option (right to buy) | −77,181 | 0 | ||
| 2026-05-28 | Fromkin Andrew J. Director | Option exercise · Stock Option (right to buy) | −16,260 | 0 | ||
| 2026-05-20 | Gloria Melanie Chief Operating Officer | Sale | −249 | $30.41 | $8K | 244,973 |
| 2026-05-20 | Gloria Melanie Chief Operating Officer | Sale | −1,168 | $32.15 | $38K | 243,805 |
| 2026-05-20 | Gloria Melanie Chief Operating Officer | Sale | −1,698 | $32.95 | $56K | 242,107 |
| 2026-05-20 | Pande Atul Director | Option exercise 10b5-1 | +6,000 | $8.43 | $51K | 122,731 |
| 2026-05-20 | Pande Atul Director | Sale 10b5-1 | −6,000 | $32.00 | $192K | 116,731 |
| 2026-05-20 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −6,000 | 270,252 | ||
| 2026-05-01 | Susman Robert Graham Director | Sale 10b5-1 | −2,502 | $27.17 | $68K | 36,394 |
| 2026-04-23 | Girao Tiago Chief Financial Officer | Sale | −25,760 | $29.62 | $763K | 247,596 |
| 2026-04-23 | Stout Jay S Chief Technology Officer | Sale | −2,754 | $29.62 | $82K | 251,685 |
| 2026-04-08 | Gloria Melanie Chief Operating Officer | Sale | −8,722 | $24.83 | $217K | 245,222 |
| 2026-04-08 | Van Tuyl Christopher Chief Legal Officer | Sale | −5,165 | $24.83 | $128K | 183,231 |
| 2026-04-08 | Stout Jay S Chief Technology Officer | Sale | −8,614 | $24.83 | $214K | 255,957 |
| 2026-04-08 | Stout Jay S Chief Technology Officer | Sale | −1,518 | $24.83 | $38K | 254,439 |
| 2026-04-07 | Torti Frank Director | Grant or award | +174,189 | 1,009,228 | ||
| 2026-04-07 | Torti Frank Director | Grant or award · Stock Option (right to buy) | +88,325 | 88,325 | ||
| 2026-04-07 | Fromkin Andrew J. Director | Grant or award | +13,880 | 99,732 | ||
| 2026-04-07 | Fromkin Andrew J. Director | Grant or award · Stock Option (right to buy) | +7,061 | 7,061 |
Page 4 of 10 · 191 trades